Journal ArticleTrials · September 16, 2024
Clinical evidence generation from and for representative populations can be improved through increased research access and ease of trial participation. To improve access and participation, a modern trial infrastructure is needed that broadens research into ...
Full textLink to itemCite
Journal ArticleNPJ digital medicine · April 2024
Artificial intelligence (AI) has the potential to transform care delivery by improving health outcomes, patient safety, and the affordability and accessibility of high-quality care. AI will be critical to building an infrastructure capable of caring for an ...
Full textOpen AccessCite
Journal ArticleCirculation · October 2023
Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US population does not eat healthy food at rates consistent with the ...
Full textCite
Book · September 9, 2023
What can be more vital to each of us than our health? Yet, despite unprecedented health care spending, the U.S. health system is substantially underperforming, especially with respect to what should be possible, given current knowledge. Although the United ...
Full textCite
Journal ArticleNEJM Catalyst Innovations in Care Delivery · July 26, 2023
Summary The demand for home- and community-based care will intensify across the world as populations age and technological advancements support innovative delivery approaches. The Future of Health, an international community of senior health leaders, colla ...
Full textCite
Journal ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · March 2022Full textCite
Journal ArticleClinical pharmacology and therapeutics · January 2022
RWE has potential to provide efficient and relevant information on the effectiveness of medical products, complementing the data generated in clinical trials; however, how RWE can support regulatory decision-making is unclear, potentially limiting its use. ...
Full textCite
Journal ArticleTrials · September 16, 2024
Clinical evidence generation from and for representative populations can be improved through increased research access and ease of trial participation. To improve access and participation, a modern trial infrastructure is needed that broadens research into ...
Full textLink to itemCite
Journal ArticleNPJ digital medicine · April 2024
Artificial intelligence (AI) has the potential to transform care delivery by improving health outcomes, patient safety, and the affordability and accessibility of high-quality care. AI will be critical to building an infrastructure capable of caring for an ...
Full textOpen AccessCite
Journal ArticleCirculation · October 2023
Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US population does not eat healthy food at rates consistent with the ...
Full textCite
Book · September 9, 2023
What can be more vital to each of us than our health? Yet, despite unprecedented health care spending, the U.S. health system is substantially underperforming, especially with respect to what should be possible, given current knowledge. Although the United ...
Full textCite
Journal ArticleNEJM Catalyst Innovations in Care Delivery · July 26, 2023
Summary The demand for home- and community-based care will intensify across the world as populations age and technological advancements support innovative delivery approaches. The Future of Health, an international community of senior health leaders, colla ...
Full textCite
Journal ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · March 2022Full textCite
Journal ArticleClinical pharmacology and therapeutics · January 2022
RWE has potential to provide efficient and relevant information on the effectiveness of medical products, complementing the data generated in clinical trials; however, how RWE can support regulatory decision-making is unclear, potentially limiting its use. ...
Full textCite
Journal ArticleBMC Public Health · June 28, 2021
BACKGROUND: The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential busi ...
Full textLink to itemCite
Journal ArticleNEJM Catalyst Innovations in Care Delivery · June 16, 2021
Telehealth utilization grew rapidly in response to the Covid-19 pandemic, enabled by significant changes to regulations, benefits, and payments by the U.S. Centers for Medicare & Medicaid Services and commercial payers. These flexibilities are now extremel ...
Full textCite
Journal ArticleCancer Med · June 2021
BACKGROUND: Quality measurement has become a priority for national healthcare reform, and valid measures are necessary to discriminate hospital performance and support value-based healthcare delivery. The Commission on Cancer (CoC) is the largest cancer-sp ...
Full textLink to itemCite
Journal ArticleJ Healthc Manag · May 2021
Accountable care organizations (ACOs) need confidence in their return on investment to implement changes in care delivery that prioritize seriously ill and high-cost Medicare beneficiaries. The objective of this study was to characterize spending on seriou ...
Full textLink to itemCite
Journal ArticleHealth Aff (Millwood) · February 2021
In 2016, in anticipation of the US presidential election and forthcoming new administration, the National Academy of Medicine launched a strategic initiative to marshal expert guidance on pressing health and health care priorities. Published as Vital Direc ...
Full textOpen AccessLink to itemCite
Journal ArticleJournal of managed care & specialty pharmacy · January 2021
Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes t ...
Full textCite
Journal ArticleJ Gen Intern Med · December 2020
BACKGROUND: The novel coronavirus disease 2019 (COVID-19) infected over 5 million United States (US) residents resulting in more than 180,000 deaths by August 2020. To mitigate transmission, most states ordered shelter-in-place orders in March and reopenin ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · December 2020
OBJECTIVES: Since 2019, the Medicare Shared Savings Program (MSSP) has allowed accountable care organizations (ACOs) to choose either retrospectively or prospectively attributed ACO populations. To understand how ACOs' choice of attribution method affects ...
Full textLink to itemCite
Journal ArticleHealthcare (Amsterdam, Netherlands) · December 2020
BackgroundPediatric accountable health communities (AHCs) are emerging collaborative models that integrate care across health and social service sectors. We aimed to identify needed capabilities and potential solutions for implementing pediatric A ...
Full textCite
Journal ArticleJ Gen Intern Med · November 9, 2020
In the original version of this paper, an author was misidentified. The corrected author listing appears here, and has been updated in the online version. ...
Full textLink to itemCite
Report · September 9, 2020
This Duke-Margolis report out provides a framework for public health officials and community leaders in schools, businesses and other institutions on how to use Covid-19 screening test strategies to operate safely and prevent further spread of the virus. A ...
Open AccessLink to itemCite
Report · August 19, 2020
Amid the SARS-CoV-2 pandemic and a crisis over inadequate and delayed testing, this report describes COVID-19 testing methods and applications, the regulatory process for approving tests, how tests are paid for, and how access to testing is obtained. The r ...
Open AccessLink to itemCite
Report · August 5, 2020
The Duke-Margolis Center for Health Policy report, “Legislative and Regulatory Steps for a National COVID-19 Testing Strategy,” outlines legislative actions and federal appropriation targets that Duke-Margolis and its collaborating experts believe are need ...
Open AccessLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · July 2020
The number of people in the United States living with Alzheimer disease (AD) is growing, resulting in significant clinical and economic impact. Substantial research investment has led to drug development in stages of AD before symptomatic dementia, such as ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · July 2020
The pipeline of new cardiovascular drugs is relatively limited compared with many other clinical areas. Challenges causing lagging drug innovation include the duration and expense of cardiovascular clinical trials needed for regulatory evaluation and appro ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · July 2020
Stroke is one of the leading causes of morbidity and mortality in the United States. While age-adjusted stroke mortality was falling, it has leveled off in recent years due in part to advances in medical technology, health care options, and population heal ...
Full textLink to itemCite
Journal ArticleCirculation. Cardiovascular quality and outcomes · July 2020
Utilization management strategies, including prior authorization, are commonly used to facilitate safe and guideline-adherent provision of new, individualized, and potentially costly cardiovascular therapies. However, as currently deployed, these approache ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · June 2020
Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising spending and whether this rise is translating into higher value. The result is increasing pressure to pay for therapies in ...
Full textCite
Journal ArticleNorth Carolina medical journal · May 2020
North Carolina has received national attention for its approach to health care payment and delivery reform. Importantly, payment reform alone is not enough to drive systematic changes in care delivery. We highlight the importance of progress in four comple ...
Full textCite
Journal ArticleCirculation. Cardiovascular quality and outcomes · May 2020
Heart failure (HF) is a leading cause of hospitalizations and readmissions in the United States. Particularly among the elderly, its prevalence and costs continue to rise, making it a significant population health issue. Despite tremendous progress in impr ...
Full textCite
Journal ArticleNorth Carolina Medical Journal · January 1, 2020
The Affordable Care Act played a major role in transitioning American health care away from fee-for-service payment. We explore the spread of payment reforms since the implementation of the ACA, both nationally and in North Carolina; the corresponding effe ...
Full textCite
Journal ArticlePediatrics · August 2019
OBJECTIVES: To describe the landscape of Medicaid and the Children's Health Insurance Program beneficiary incentive programs for child health and garner key stakeholder insights on incentive program rationale, child and family engagement, and program evalu ...
Full textLink to itemCite
Journal ArticleHealth Aff (Millwood) · June 2019
Care for people living with serious illness is suboptimal for many reasons, including underpayment for key services (such as care coordination and social supports) in fee-for-service reimbursement. Accountable care organizations (ACOs) have potential to im ...
Full textLink to itemCite
Journal ArticleHealth affairs (Project Hope) · May 2019
The ability of accountable care organizations (ACOs) to continue reducing costs and improving quality depends on understanding what affects their survival. We examined such factors for survival in the Medicare Shared Savings Program (MSSP) of 624 ACOs betw ...
Full textCite
Journal ArticleHepatology · March 2019
Healthcare reimbursement is shifting from fee-for-service to fee-for-value. Cirrhosis, which costs the U.S. healthcare system as much as heart failure, is a prime target for value-based care. This article describes models in which physician groups or healt ...
Full textLink to itemCite
Journal ArticleJournal of general internal medicine · March 2019
Medications are one of the fastest growing sources of costs in the health system and the cornerstone of disease management. Despite extensive attention around drug pricing, medications have largely been excluded from CMS-derived, value-based payment models ...
Full textCite
Journal ArticleHealth Aff (Millwood) · March 2019
Medicaid programs are increasingly adopting incentive programs to improve health behaviors among beneficiaries. There is limited evidence on what incentives are being offered to Medicaid beneficiaries, how programs are engaging beneficiaries, and how progr ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · February 2019
OBJECTIVES: To better understand the prevalence of US value-based payment arrangements (VBAs), their characteristics, and the factors that facilitate their success or act as barriers to their implementation. STUDY DESIGN: Surveys were administered to a con ...
Link to itemCite
Journal ArticleCirculation · February 2019
Although advances in care have spurred improvements in cardiovascular outcomes, cardiovascular disease remains the leading cause of death in the United States and around the world. Previous declines in cardiovascular disease mortality have slowed and even ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · January 2019
Seven former commissioners of the Food and Drug Administration (FDA) from both sides of the political aisle recommend that the FDA be moved out of the Department of Health and Human Services and reconfigured as an independent federal agency. We believe tha ...
Full textCite
Journal ArticleJ Am Coll Cardiol · June 12, 2018
As we enter the information age of health care, digital health technologies offer significant opportunities to optimize both clinical care delivery and clinical research. Despite their potential, the use of such information technologies in clinical care an ...
Full textLink to itemCite
Journal ArticleGlobal heart · June 2018
Four decades ago, U.S. life expectancy was within the same range as other high-income peer countries. However, during the past decades, the United States has fared worse in many key health domains resulting in shorter life expectancy and poorer health-a he ...
Full textCite
Journal ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · June 2018
As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Va ...
Full textCite
Journal ArticleJAMA cardiology · January 2018
Importance:The US health care system faces an unsustainable trajectory of high costs and inconsistent outcomes. The fee-for-service payment model has contributed to inefficiency, and new payment methods are a promising approach to improving value. Health r ...
Full textCite
Journal ArticleAnnual review of medicine · January 2018
The postelection efforts to repeal, replace, or modify the Affordable Care Act (ACA) suggest that the debate over healthcare coverage will remain contentious, particularly because of the high and rising cost of health care. Feasible, potentially bipartisan ...
Full textCite
Journal ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · January 2018
Patient-centered medical home models are fundamental to the advanced alternative payment models defined in the Medicare Access and Children's Health Insurance Plan Reauthorization Act (MACRA). The patient-centered medical home is a model of healthcare deli ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · November 2017
Over the past decade the Ministry of Health of Nepal and the nonprofit Possible have partnered to deliver primary and secondary health care via a public-private partnership. We applied an accountable care framework that we previously developed to describe ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · November 2017
Policy makers and providers are under increasing pressure to find innovative approaches to achieving better health outcomes as efficiently as possible. Accountable care, which holds providers accountable for results rather than specific services, is emergi ...
Full textCite
Journal ArticleJAMA · April 11, 2017
IMPORTANCE: Recent discussion has focused on questions related to the repeal and replacement of portions of the Affordable Care Act (ACA). However, issues central to the future of health and health care in the United States transcend the ACA provisions rec ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · April 2017
Telehealth offers an innovative approach to improve heart failure care that expands beyond traditional management strategies. Yet the use of telehealth in heart failure is infrequent because of several obstacles. Fundamentally, the evidence is inconsistent ...
Full textLink to itemCite
Journal ArticleHealth affairs (Project Hope) · March 2017
Driven by evidence of continuing gaps in health care quality and efficiency and inspired by the emergence of new value-based payment models, both large and small health care organizations are developing and deploying a wide range of care delivery innovatio ...
Full textCite
Journal ArticleValue Health · February 2017
Rising costs without perceived proportional improvements in quality and outcomes have motivated fundamental shifts in health care delivery and payment to achieve better value. Aligned with these efforts, several value assessment frameworks have been introd ...
Full textLink to itemCite
Journal ArticleJAMA cardiology · February 2017
ImportanceRecent health care reforms aim to increase patient access, reduce costs, and improve health care quality as payers turn to payment reform for greater value. Cardiologists need to understand emerging payment models to succeed in the evolv ...
Full textCite
Journal ArticleJournal of managed care & specialty pharmacy · February 2017
Payment for health care services, including oncology services, is shifting from volume-based fee-for-service to value-based accountable care. The objective of accountable care is to support providers with flexibility and resources to reform care delivery, ...
Full textCite
Journal ArticleClinical pharmacology and therapeutics · January 2017
Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods an ...
Full textCite
Journal ArticleDrug development and industrial pharmacy · January 2017
ContextPolicy and legislative efforts to improve the biomedical innovation process must rely on a detailed and thorough analysis of drug development and industry output.ObjectiveAs part of our efforts to build a publicly-available databas ...
Full textCite
Journal ArticlePediatrics · August 2016
Background and objectivesPayers are implementing alternative payment models that attempt to align payment with high-value care. This study calculates the breakeven capitated payment rate for a midsize pediatric practice and explores how several di ...
Full textCite
Journal ArticleThe American journal of managed care · August 2016
Current alternative payment models (APMs) that move away from traditional fee-for-service payment often have explicit goals to reduce utilization in episodic settings, such as emergency departments (ED). We apply the new HHS payment reform taxonomy to illu ...
Cite
Journal ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · April 2016
Fee-for-service payments encourage high-volume services rather than high-quality care. Alternative payment models (APMs) aim to realign financing to support high-value services. The 2 main components of gastroenterologic care, procedures and chronic care m ...
Full textCite
Journal ArticleThe American journal of managed care · October 2015
ObjectivesA primary objective of accountable care is to support providers in reforming care to improve outcomes and lower costs. Gaps in accountable care measure sets may cause missed opportunities for improvement and missed signals of problems in ...
Cite
Journal ArticleHealth affairs (Project Hope) · September 2015
The rising prevalence, health burden, and cost of chronic diseases such as diabetes have accelerated global interest in innovative care models that use approaches such as community-based care and information technology to improve or transform disease preve ...
Full textCite
Journal ArticleHealthcare (Amsterdam, Netherlands) · September 2015
To assist practices and institutions throughout the country in implementing clinical redesign supported by - and aligned with - payment reform, we present a case study of the New Mexico Cancer Center (NMCC) based on numerous stakeholder interviews, literat ...
Full textCite
Journal ArticleClinical pharmacology and therapeutics · May 2015
Off-label drug use is common in oncology, due in part to significant unmet medical need, the rarity of many cancers, and the difficulty of conducting randomized controlled trials (RCTs) to support labeling of every drug in every disease setting. As new dru ...
Full textCite
Journal ArticleJournal of oncology practice · May 2015
Cancer care is transforming, moving toward increasingly personalized treatment with the potential to save and improve many more lives. Many oncologists and policymakers view current fee-for-service payments as an obstacle to providing more efficient, high- ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · February 2015
Multidrug-resistant bacterial diseases pose serious and growing threats to human health. While innovation is important to all areas of health research, it is uniquely important in antibiotics. Resistance destroys the fruit of prior research, making it nece ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · February 2015
New drugs and biologics have had a tremendous impact on the treatment of many diseases. However, available measures suggest that pharmaceutical innovation has remained relatively flat, despite substantial growth in research and development spending. We rev ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · September 2014
Accountable care--a way to align health care payments with patient-focused reform goals--is currently being pursued in the United States, but its principles are also being applied in many other countries. In this article we review experiences with such ref ...
Full textCite
Journal ArticlePopulation health management · January 2013
Accountable care organizations (ACOs) and the more general movement toward accountable care, in which payments are aligned directly with improvements in quality and cost, are intended to increase the incentives and support for higher value in health care. ...
Full textCite
Journal ArticleJournal of Oncology Practice · January 1, 2013
Cancer care suffers from many of the well-known flaws in the American health care delivery system. Most of the care delivery shortfalls and inefficiencies can be tied, in part, back to payment systems that support high-cost procedures rather than focusing ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · July 2012
The US health care system is characterized by fragmentation and misaligned incentives, which creates challenges for both providers and recipients. These challenges are magnified for older adults who receive long-term services and supports. The Affordable C ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · April 2011
Better data on the quality of health care being delivered in the United States are urgently needed if efforts to reform the nation's health care system are to succeed. This paper describes a "distributed data approach" to computing performance results whil ...
Full textCite
Journal ArticleNature reviews. Drug discovery · February 2011
A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers. ...
Full textCite
ConferenceThe journal of economic perspectives : a journal of the American Economic Association · January 2011
This paper focuses on a broad movement toward a fundamentally different way of paying healthcare providers. The approach reaches beyond the old dichotomies about whether healthcare providers are reimbursed on a fee-for-service or a "capitated" or per-perso ...
Full textCite
Journal ArticleThe American journal of managed care · November 2010
In September 2009, we released a set of concrete, feasible steps that could achieve the goal of significantly slowing spending growth while improving the quality of care. We stand by these recommendations, but they need to be updated in light of the new Pa ...
Cite
Journal ArticleHealth affairs (Project Hope) · October 2010
The American Recovery and Reinvestment Act of 2009 included new funding for developing better evidence about health interventions, with a down payment of $1.1 billion for comparative effectiveness research. Our analysis of funds allocated in the legislatio ...
Full textCite
Journal ArticleStatistics in medicine · August 2010
Comparative effectiveness research (CER) has received substantial attention as a potential approach for improving health outcomes while lowering costs of care, and for improving the relevance and quality of clinical and health services research. The Instit ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · August 2010
Improved access to health care is essential if we are to fill the striking gaps between how healthy Americans are and how healthy they could be. But access alone is not enough. Health and longevity are also profoundly influenced by where and how Americans ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · May 2010
The concept of accountable care organizations (ACOs) has been set forth in recently enacted national health reform legislation as a strategy to address current shortcomings in the U.S. health care system. This paper focuses on implementation issues related ...
Full textCite
Journal ArticleHealth economics · October 2009
The Technological Change in Health Care Research Network collected unique patient-level data on three procedures for treatment of heart attack patients (catheterization, coronary artery bypass grafts and percutaneous transluminal coronary angioplasty) for ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · March 2009
To succeed, health care reform must slow spending growth while improving quality. We propose a new approach to help achieve more integrated and efficient care by fostering local organizational accountability for quality and costs through performance measur ...
Full textCite
Journal ArticleThe American journal of cardiology · April 2006
Although the quality of health care would logically seem to be a universal concept, this study hypothesized that physicians and their patients could differ in their perceptions of "high-quality care" and that those beliefs might vary by country. Such a mis ...
Full textCite
Journal ArticleJournal of Public Economics · January 1, 2006
The Medicare program transfers nearly $300 billion annually from taxpayers to beneficiaries. This paper considers the incidence of such transfers in the context of a life cycle model with uncertainty about future health care expenditures. We find the distr ...
Full textCite
Journal ArticleCirculation · October 2005
BackgroundAfrican Americans are more likely to be seen by physicians with less clinical training or to be treated at hospitals with longer average times to acute reperfusion therapies. Less is known about differences in health outcomes. This repor ...
Full textCite
Journal ArticleJournal of health economics · January 2005
This paper identifies which types of patients and hospitals have abusive Medicare billings that are responsive to law enforcement. For a 20% random sample of elderly Medicare beneficiaries hospitalized from 1994 to 1998 with one or more of six illnesses th ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · May 2004
Departing Food and Drug Administration (FDA) Commissioner Mark McClellan outlines the major initiatives of his sixteen-month tenure at the agency, including an expanded role for economic analysis in FDA policy, steps to promote "e-prescribing" and other in ...
Full textCite
Journal ArticleHealth services research · April 2004
ObjectiveAlthough an increasing fraction of Medicare beneficiaries die outside the hospital, the proportion of total Medicare expenditures attributable to care in the last year of life has not dropped. We sought to determine whether disproportiona ...
Full textCite
Journal ArticleHealth services research · February 2004
ObjectiveTo discuss and quantify the incentives that Medicare managed care plans have to avoid (through selective enrollment or disenrollment) people who are at risk for very high costs, focusing on Medicare beneficiaries in the last year of life- ...
Full textCite
Journal ArticleJournal of health economics · January 2004
To assess the consequences of advance medical directives--which explicitly specify a patient's preferences for one or more specific types of medical treatment in the event of a loss of competence--we analyze the medical care of elderly Medicare beneficiari ...
Full textCite
Journal ArticleHealth Affairs · December 1, 2003
The president's proposal to introduce tax credits for the purchase of health insurance will enable millions of Americans to purchase private health insurance, improving the functioning of private markets, empowering patients to make informed decisions, and ...
Cite
Journal ArticleMedical care · July 2003
BackgroundStudies from the early 1990s have documented greater intensity of treatment for patients with acute myocardial infarction (AMI) in the United States compared with Canada, with little difference in health outcomes. Little is known about w ...
Full textCite
Journal ArticleJournal of Political Economy · June 1, 2003
Health care report cards-public disclosure of patient health outcomes at the level of the individual physician or hospital or both-may address important informational asymmetries in markets for health care, but they may also give doctors and hospitals ince ...
Full textCite
Journal ArticleAnn Intern Med · May 6, 2003
BACKGROUND: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is a potentially useful but expensive test to diagnose solitary pulmonary nodules. OBJECTIVE: To evaluate the cost-effectiveness of strategies for pulmonary nodule diagnosis an ...
Full textLink to itemCite
Journal ArticleJournal of health economics · November 2002
Previous research suggests that "direct" reforms to the liability system-reforms designed to reduce the level of compensation to potential claimants-reduce medical expenditures without important consequences for patient health outcomes. We extend this rese ...
Full textCite
Journal ArticleAnnals of internal medicine · October 2002
BackgroundPatients with end-stage renal disease are known to have decreased survival after myocardial infarction, but the association of less severe renal dysfunction with survival after myocardial infarction is unknown.ObjectivesTo deter ...
Full textCite
Journal ArticleArchives of internal medicine · August 2002
BackgroundWe examined deaths of Medicare beneficiaries in Massachusetts and California to evaluate the effect of managed care on the use of hospice and site of death and to determine how hospice affects the expenditures for the last year of life.< ...
Full textCite
Journal ArticleThe American journal of medicine · August 2002
PurposeTo determine the effect of patient refusal on racial and sex differences in the use of coronary angiography and in outcomes among elderly patients with acute myocardial infarction.Subjects and methodsWe included Medicare beneficiar ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · July 2002
The president's proposal to introduce tax credits for the purchase of health insurance will enable millions of Americans to purchase private health insurance, improving the functioning of private markets, empowering patients to make informed decisions, and ...
Full textCite
Journal ArticleJournal of Public Economics · May 14, 2002
Because fee-for-service health insurance insulates providers from the costs of treatment decisions, it may lead to "defensive medicine" - precautionary treatment with minimal expected medical benefit administered out of fear of legal liability. By giving p ...
Full textCite
Journal ArticleThe American journal of medicine · May 2002
PurposeThe implantable cardioverter defibrillator has been assessed in randomized trials, but the generalizability of trial results to broader clinical settings is unclear. Our purpose was to evaluate the outcomes and costs of defibrillator use in ...
Full textCite
Journal ArticleThe American journal of medicine · February 2002
PurposeTo determine if greater managed care market share is associated with greater use of recommended therapies for fee-for-service patients with acute myocardial infarction.Subjects and methodsWe examined the care of 112,900 fee-for-ser ...
Full textCite
Journal ArticleAmerican Heart Journal · January 1, 2002
Background. Treatment options for patients with ventricular arrhythmias have undergone major changes in the last 2 decades. Trends in use of invasive procedures, clinical outcomes, and expenditures have not been well documented. Methods. We used administra ...
Full textCite
ConferenceThe Rand journal of economics · January 2002
To develop new evidence on how hospital ownership and other aspects of hospital market composition affect health care productivity, we analyze longitudinal data on the medical expenditures and health outcomes of the vast majority of nonrural elderly Medica ...
Full textCite
Journal ArticleAmerican Heart Journal · January 1, 2002
Background. The patterns of adoption of the implantable cardioverter defibrillator (ICD) and the outcomes of its use have not been well documented in general, unselected populations. The purpose of this study was to document the impact of the ICD in widesp ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · September 2001
Medical technology is valuable if the benefits of medical advances exceed the costs. We analyze technological change in five conditions to determine if this is so. In four of the conditions--heart attacks, low-birthweight infants, depression, and cataracts ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · May 2001
Although technological change is a hallmark of health care worldwide, relatively little evidence exists on whether changes in health care differ across the very different health care systems of developed countries. We present new comparative evidence on he ...
Full textCite
Journal ArticleThe American journal of medicine · April 2001
PurposeAngiotensin converting-enzyme (ACE) inhibitors decrease mortality after myocardial infarction among patients with depressed left ventricular function. Beta blockers may also improve survival in these patients. We compared the relative effec ...
Full textCite
Journal ArticleThe American journal of medicine · February 2001
PurposeTo review the trends in treatment and survival for patients with acute myocardial infarction over the last 20 years.Material and methodsStudies were identified through MEDLINE searches and review of study bibliographies. Additional ...
Full textCite
Journal ArticleJournal of Legal Studies · January 1, 2001
The growth of managed care has prompted numerous questions about its effect on the quality of health care. This paper reviews evidence on the effects of managed care on quality. Most comparisons of care for patients in different plans within similar market ...
Full textCite
Journal ArticleHealth services research · December 2000
ObjectiveTo determine the effect of treatment by a cardiologist on mortality of elderly patients with acute myocardial infarction (AMI, heart attack), accounting for both measured confounding using risk-adjustment techniques and residual unmeasure ...
Cite
Journal ArticleArchives of internal medicine · September 2000
ContextAngiotensin-converting enzyme (ACE) inhibitors have been shown to decrease mortality in patients with myocardial infarction and depressed left ventricular function, but physicians may be reluctant to prescribe ACE inhibitors to patients wit ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · March 2000
We review the policy concerns underlying some of the most contentious issues that must be resolved prior to the enactment of a Medicare drug benefit. We consider critical issues both in benefit design-targeted versus universal eligibility, benefit subsidie ...
Full textCite
Journal ArticleQuarterly Journal of Economics · January 1, 2000
We study the consequences of hospital competition for Medicare beneficiaries' heart attack care from 1985 to 1994. We examine how relatively exogenous determinants of hospital choice such as travel distances influence the competitiveness of hospital market ...
Full textCite
Journal ArticleThe journal of economic perspectives : a journal of the American Economic Association · January 2000
This paper presents an overview of the Medicare reform debate. I begin by reviewing some of the features of Medicare and then turn to a discussion of reforms, both on the benefits side and on the financing side of the program. The reform proposals raise di ...
Full textCite
Journal ArticleInquiry : a journal of medical care organization, provision and financing · January 2000
This paper applies instrumental variable (IV) techniques and estimates the average benefits of invasive surgical treatments for marginal acute myocardial infarction (AMI) patients by insurance coverage. The study uses data from the Agency for Healthcare Re ...
Cite
Journal ArticleThe Rand journal of economics · January 2000
Integrating the health services and insurance industries, as health maintenance organizations (HMOs) do, could lower expenditure by reducing either the quantity of services or unit price or both. We compare the treatment of heart disease in HMOs and tradit ...
Full textCite
Journal ArticleHealth affairs (Project Hope) · January 1999
As Medicare's share of federal spending and gross domestic product (GDP) rises, the program may have increasingly important consequences not only for the health of Americans but also for their net income and financial well-being. We use incidence analysis ...
Full textCite
Journal ArticleTransplantation · December 1998
ObjectivesTo estimate the risks and costs of end-stage renal disease (ESRD) after heart transplantation.BackgroundPrevious studies have shown high rates of ESRD among solid-organ transplant patients, but the relevance of these studies for ...
Full textCite
Journal ArticleAnnual review of public health · January 1998
We describe an econometric technique, instrumental variables, that can be useful in estimating the effectiveness of clinical treatments in situations when a controlled trial has not or cannot be done. This technique relies upon the existence of one or more ...
Full textCite
Journal ArticleQuarterly Journal of Economics · January 1, 1998
We address long-standing problems in measuring medical inflation by estimating two types of price indices. The first, a Service Price Index, prices specific medical services, as does the current CPI. The second, a Cost of Living Index, measures a quality-a ...
Full textCite
Journal ArticleJournal of Econometrics · January 1, 1997
We use panel instrumental variables techniques to estimate incremental mortality and cost effects of intensive procedures for treating heart attacks among the elderly. We identify incremental effects by comparing trends in procedure use, hospital costs, an ...
Full textCite
Journal ArticleJournal of Economics and Management Strategy · January 1, 1997
Reimbursement systems for health-care providers are very complex, like the production systems that they regulate. This complexity has led to some important misperceptions about the incentive consequences of major reimbursement reforms. One example is the p ...
Full textCite
Journal ArticleProceedings of the National Academy of Sciences of the United States of America · November 1996
Whether the U.S. health care system supports too much technological change-so that new technologies of low value are adopted, or worthwhile technologies become overused-is a controversial question. This paper analyzes the marginal value of technological ch ...
Full textCite
Journal ArticleQuarterly Journal of Economics · January 1, 1996
"Defensive medicine" is a potentially serious social problem: if fear of liability drives health care providers to administer treatments that do not have worthwhile medical benefits, then the current liability system may generate inefficiencies much larger ...
Full textCite
Journal ArticleJAMA: The Journal of the American Medical Association · January 1, 1995
We used empirical data on treatments and outcomes of elderly AMI patients to estimate the mortality consequences of the additional catheterization and revascularization procedures performed by the most intensive hospitals relative to other hospitals. In co ...
Full textCite
Journal ArticleJAMA · September 1994
ObjectiveTo determine the effect of more intensive treatments on mortality in elderly patients with acute myocardial infarction (AMI).DesignAnalysis of incremental treatment effects using differential distances as instrumental variables t ...
Full textCite
Journal ArticleMedical care · July 1992
The RAND-UCLA Health Services Utilization Study previously analyzed the appropriateness of use of carotid endarterectomy based on a literature review and global expert judgments. In this study, for 45 of the same clinical indications used in the RAND-UCLA ...
Cite